Format

Send to

Choose Destination
Prev Chronic Dis. 2017 Sep 7;14:E77. doi: 10.5888/pcd14.170171.

Aspirin for Prevention of Cardiovascular Disease.

Author information

1
Office of Health Data and Research, Mississippi State Department of Health, 570 East Woodrow Wilson Drive, Jackson, MS 39215. Email: vincent.mendy@msdh.ms.gov.
2
Office of Health Data and Research, Mississippi State Department of Health, Jackson, Mississippi.

Abstract

We used data from the 2013 Mississippi Behavioral Risk Factor Surveillance System to examine aspirin use for the prevention of primary and secondary cardiovascular disease (CVD), based on the 2009 US Preventive Services Task Force (USPSTF) guidelines, among Mississippi men (aged 45-79 y) and women (aged 55-79 y) and to explore differences in aspirin use by sociodemographic characteristics. Among those without CVD, 39.1% of men and 45.9% of women reported taking aspirin, and among those with CVD, 85.9% of men and 85.1% of women reported taking aspirin. Data on preventive use of aspirin by sociodemographic characteristics yielded mixed results.

PMID:
28880838
PMCID:
PMC5590489
DOI:
10.5888/pcd14.170171
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Centers for Disease Control and Prevention Icon for PubMed Central
Loading ...
Support Center